Vol. 5, Issue 2, Part A (2023)

The human microbiome, the collective genome of the trillions of microorganisms residing in and on the human body, plays a pivotal role in the metabolism of pharmaceuticals, influencing drug efficacy and safety. This emerging field of study has significant implications for personalized medicine, offering insights into inter individual variability in drug response, potential side effects, and therapeutic outcomes. This paper delves into the mechanisms by which the microbiome influences drug metabolism, explores the clinical implications of these interactions, and considers future directions for integrating microbiome insights into drug development and personalized therapy.